201. The Mechanism of the Selective Antiproliferation Effect of Guanine-Based Biomolecules and Its Compensation
- Author
-
Luyao Shen, Dihua Shangguan, Junyan Wang, Tao Bing, Nan Zhang, Linlin Wang, Junqing He, and Xiangjun Liu
- Subjects
0301 basic medicine ,Guanine ,Deamination ,01 natural sciences ,Biochemistry ,Catalysis ,Cell Line ,03 medical and health sciences ,Guanine deaminase ,chemistry.chemical_compound ,Humans ,Nucleotide ,Cell Proliferation ,Guanine Deaminase ,chemistry.chemical_classification ,DNA synthesis ,Nucleotides ,010405 organic chemistry ,Oligonucleotide ,Nucleosides ,General Medicine ,Xanthine ,0104 chemical sciences ,030104 developmental biology ,chemistry ,Molecular Medicine ,Cytosine - Abstract
As endogenous biomolecules, guanine, guanine-based nucleosides, and nucleotides are essential for cellular DNA/RNA synthesis, energy metabolism, and signal transduction. However, these biomolecules have been found to have a cell-specific antiproliferation effect at higher concentrations, and the mechanism is unclear. In this study, we demonstrate that guanine deaminase (GDA) is a major factor in determining the cell-type selectivity to the antiproliferation effect of guanine-based biomolecules. GDA catalyzes the deamination of guanine to xanthine, which is an essential part of the guanine degradation pathway. GDA deficient cells could not efficiently remove the excess guanine-based biomolecules. These excess molecules disturb the metabolism of adenine-, cytosine-, and thymine-based nucleotides; subsequently inhibit the DNA synthesis and cell growth; and eventually result in the apoptosis/death of GDA deficient cells. The inhibition of DNA synthesis could be relieved by simultaneous addition of adenine- and cytosine-based nucleosides, and the inhibited DNA synthesis could be restarted by post addition of them, which subsequently reduces the antiproliferation effect of guanine-based biomolecules or even totally restores the cell proliferation. These results provide important information for the development of guanine-based drugs or guanine-rich oligonucleotide drugs, as well as for the safety evaluation of food with a high level of guanine-based compounds.
- Published
- 2019
- Full Text
- View/download PDF